EP0324725A1 — A pharmaceutical composition
Assigned to Pfizer Health AB · Expires 1989-07-19 · 37y expired
What this patent protects
The invention relates to an ordered mixture of particles of a water-soluble, pharmaceutical carrier substance and smaller particles of at least one pharmaceutically active substance which adhere to the carrier particles. In accordance with the invention a pharmaceutical disinte…
USPTO Abstract
The invention relates to an ordered mixture of particles of a water-soluble, pharmaceutical carrier substance and smaller particles of at least one pharmaceutically active substance which adhere to the carrier particles. In accordance with the invention a pharmaceutical disintegrant is incorporated in the carrier particles. The invention also relates to pharmaceutical preparations which include one such ordered mixture, and also to a method of producing such preparations and to the use of the ordered mixtures in such preparations.
Drugs covered by this patent
- Subutex (Buprenorphine Hydrochloride) · Indivior
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.